Cargando…
SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus
Case series Patients: Female, 29-year-old • Female, 34-year-old • Female, 24-year-old • Female, 39-year-old • Female, 46-year-old Final Diagnosis: COVID-19 • SARS-CoV-2 Symptoms: Anosmia • asthenia • chest pain • chills • diarrhea • dry cough • dyspnea • fever • headache • myalgias • odynophagia Med...
Autores principales: | Zurita, María Fernanda, Arreaga, Adriana Iglesias, Chavez, Adriana A Luzuriaga, Zurita, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526941/ https://www.ncbi.nlm.nih.gov/pubmed/32978364 http://dx.doi.org/10.12659/AJCR.927304 |
Ejemplares similares
-
Measurement of Disease Activity in Ecuadorian Patients with Rheumatoid Arthritis: Does RAPID3 Correlate with Traditional Indexes?
por: Zurita, María Fernanda, et al.
Publicado: (2019) -
Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study
por: Sevillano, Gabriela, et al.
Publicado: (2021) -
SARS-CoV-2 and Systemic Lupus Erythematosus
por: Thanou, Aikaterini, et al.
Publicado: (2021) -
An On-Line Cross-Sectional Questionnaire to Assess Knowledge of COVID-19 Pandemic among Citizens Tested for the SARS-CoV-2 Virus in Quito and Ibarra, Ecuador
por: Ortega-Paredes, David, et al.
Publicado: (2021) -
Hydroxychloroquine ototoxicity in a patient with systemic lupus
erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018)